1. New Developments in the Second-Line Treatment of Metastatic Colorectal Cancer: Potential Place in Therapy

   • Dirk Arnold
   • Alexander Stein

   Leading Article 07 June 2013 Pages: 883 - 891

   

2. HIV-Associated Neurocognitive Disorders: Perspective on Management Strategies

   • Linda Nabha
   • Lan Duong
   • Joseph Timpone

   Therapy in Practice 04 June 2013 Pages: 893 - 905

3. Recent Developments in Drug Therapy for Cushing’s Disease

   • Rob van der Pas
   • Wouter W. de Herder
   • Richard A. Feelders

   Review Article 05 June 2013 Pages: 907 - 918

   

4. Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity

   • Richard J. Hamill

   Review Article 01 June 2013 Pages: 919 - 934

5. Teduglutide: A Review of its Use in the Treatment of Patients with Short Bowel Syndrome

   • Celeste B. Burness
   • Paul L. McCormack

   Adis Drug Evaluation 01 June 2013 Pages: 935 - 947

   

6. Loteprednol Etabonate Ophthalmic Gel 0.5 %: A Review of Its Use in Post-Operative Inflammation and Pain Following Ocular Surgery

   • Katherine A. Lyseng-Williamson

   Adis Drug Evaluation 06 June 2013 Pages: 949 - 958

   

7. Landiolol: A Review of its use in Intraoperative and Postoperative Tachyarrhythmias

   • Greg L. Plosker

   Adis Drug Evaluation 13 June 2013 Pages: 959 - 977

   

8. Canagliflozin: First Global Approval

   • Shelley Elkinson
   • Lesley J. Scott

   R&D Insight Report 01 June 2013 Pages: 979 - 988

   

9. Metreleptin: First Global Approval

   • Ken Chou
   • Caroline M. Perry

   R&D Insight Report 06 June 2013 Pages: 989 - 997